These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


104 related items for PubMed ID: 21492878

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Early neurological deterioration within 24 hours after intravenous rt-PA therapy for stroke patients: the Stroke Acute Management with Urgent Risk Factor Assessment and Improvement rt-PA Registry.
    Mori M, Naganuma M, Okada Y, Hasegawa Y, Shiokawa Y, Nakagawara J, Furui E, Kimura K, Yamagami H, Kario K, Okuda S, Koga M, Minematsu K, Toyoda K.
    Cerebrovasc Dis; 2012; 34(2):140-6. PubMed ID: 22854333
    [Abstract] [Full Text] [Related]

  • 3. Pretreatment ASPECTS on DWI predicts 3-month outcome following rt-PA: SAMURAI rt-PA Registry.
    Nezu T, Koga M, Kimura K, Shiokawa Y, Nakagawara J, Furui E, Yamagami H, Okada Y, Hasegawa Y, Kario K, Okuda S, Nishiyama K, Naganuma M, Minematsu K, Toyoda K.
    Neurology; 2010 Aug 10; 75(6):555-61. PubMed ID: 20697108
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Effect of serum lipid levels on stroke outcome after rt-PA therapy: SAMURAI rt-PA registry.
    Makihara N, Okada Y, Koga M, Shiokawa Y, Nakagawara J, Furui E, Kimura K, Yamagami H, Hasegawa Y, Kario K, Okuda S, Naganuma M, Toyoda K.
    Cerebrovasc Dis; 2012 Aug 10; 33(3):240-7. PubMed ID: 22261711
    [Abstract] [Full Text] [Related]

  • 6. Predictors of major neurological improvement after intravenous thrombolysis in acute ischemic stroke: a hospital-based study from south India.
    Boddu DB, Srinivasarao Bandaru VC, Reddy PG, Madhusudan M, Rukmini MK, Suryaprabha T, Jabeen SA, Suvarna A, Jayalakshmi SS, Meena AK, Borgohain R, Kaul S.
    Neurol India; 2010 Aug 10; 58(3):403-6. PubMed ID: 20644268
    [Abstract] [Full Text] [Related]

  • 7. Relationship between chronic atrial fibrillation and worse outcomes in stroke patients after intravenous thrombolysis.
    Seet RC, Zhang Y, Wijdicks EF, Rabinstein AA.
    Arch Neurol; 2011 Nov 10; 68(11):1454-8. PubMed ID: 22084129
    [Abstract] [Full Text] [Related]

  • 8. Rate of antithrombotic drug use and clinical outcomes according to CHADS2 scores in patients with an initial cardioembolic stroke who had nonvalvular atrial fibrillation.
    Deguchi I, Ogawa H, Ohe Y, Nemoto M, Tanahashi N.
    J Stroke Cerebrovasc Dis; 2013 Aug 10; 22(6):846-50. PubMed ID: 22819543
    [Abstract] [Full Text] [Related]

  • 9. Atrial fibrillation as an independent predictor for no early recanalization after IV-t-PA in acute ischemic stroke.
    Kimura K, Iguchi Y, Yamashita S, Shibazaki K, Kobayashi K, Inoue T.
    J Neurol Sci; 2008 Apr 15; 267(1-2):57-61. PubMed ID: 17964602
    [Abstract] [Full Text] [Related]

  • 10. Prediction of long-term outcome by percent improvement after the first day of thrombolytic treatment in stroke patients.
    Nam HS, Lee KY, Han SW, Kim SH, Lee JY, Ahn SH, Kim DJ, Kim DI, Nam CM, Heo JH.
    J Neurol Sci; 2009 Jun 15; 281(1-2):69-73. PubMed ID: 19304298
    [Abstract] [Full Text] [Related]

  • 11. Recanalization between 1 and 24 hours after t-PA therapy is a strong predictor of cerebral hemorrhage in acute ischemic stroke patients.
    Kimura K, Iguchi Y, Shibazaki K, Kobayashi K, Uemura J, Aoki J, Yamashita S, Terasawa Y, Matsumoto N.
    J Neurol Sci; 2008 Jul 15; 270(1-2):48-52. PubMed ID: 18304581
    [Abstract] [Full Text] [Related]

  • 12. Recanalization within one hour after intravenous tissue plasminogen activator is associated with favorable outcome in acute stroke patients.
    Kimura K, Iguchi Y, Shibazaki K, Aoki J, Watanabe M, Kobayashi K, Sakamoto Y.
    Eur Neurol; 2010 Jul 15; 63(6):331-6. PubMed ID: 20516694
    [Abstract] [Full Text] [Related]

  • 13. Intravenous recombinant tissue plasminogen activator therapy for acute ischemic stroke: initial Israeli experience.
    Schwammenthal Y, Drescher MJ, Merzeliak O, Tsabari R, Bruk B, Feibel M, Hoffman C, Bakon M, Rotstein Z, Chapman J, Tanne D.
    Isr Med Assoc J; 2004 Feb 15; 6(2):70-4. PubMed ID: 14986460
    [Abstract] [Full Text] [Related]

  • 14. Does mild deficit for patients with stroke justify the use of intravenous tissue plasminogen activator?
    Hassan AE, Zacharatos H, Hassanzadeh B, El-Gengaihy A, AlKawi A, Shhadeh A, Kirmani JF.
    J Stroke Cerebrovasc Dis; 2010 Mar 15; 19(2):116-20. PubMed ID: 20189087
    [Abstract] [Full Text] [Related]

  • 15. Pre-admission CHADS2 score is related to severity and outcome of stroke.
    Sato S, Yazawa Y, Itabashi R, Tsukita K, Fujiwara S, Furui E.
    J Neurol Sci; 2011 Aug 15; 307(1-2):149-52. PubMed ID: 21570092
    [Abstract] [Full Text] [Related]

  • 16. NIHSS-time score easily predicts outcomes in rt-PA patients: the SAMURAI rt-PA registry.
    Aoki J, Kimura K, Koga M, Kario K, Nakagawara J, Furui E, Shiokawa Y, Hasegawa Y, Okuda S, Yamagami H, Okada Y, Shibazaki K, Sakamoto Y, Toyoda K.
    J Neurol Sci; 2013 Apr 15; 327(1-2):6-11. PubMed ID: 23433814
    [Abstract] [Full Text] [Related]

  • 17. Thrombolytic therapy for acute stroke in the elderly: an emergent condition in developing countries.
    Martins SC, Friedrich MA, Brondani R, de Almeida AG, de Araújo MD, Chaves ML, Berger JR, Massaro AR.
    J Stroke Cerebrovasc Dis; 2011 Apr 15; 20(5):459-64. PubMed ID: 20813552
    [Abstract] [Full Text] [Related]

  • 18. Chronic kidney disease and CHADS(2) score independently predict cardiovascular events and mortality in patients with nonvalvular atrial fibrillation.
    Nakagawa K, Hirai T, Takashima S, Fukuda N, Ohara K, Sasahara E, Taguchi Y, Dougu N, Nozawa T, Tanaka K, Inoue H.
    Am J Cardiol; 2011 Mar 15; 107(6):912-6. PubMed ID: 21247518
    [Abstract] [Full Text] [Related]

  • 19. Intravenous recombinant tissue plasminogen activator therapy for stroke patients receiving maintenance hemodialysis: the Stroke Acute Management with Urgent Risk-Factor Assessment and Improvement (SAMURAI) rt-PA registry.
    Naganuma M, Mori M, Nezu T, Makihara N, Koga M, Okada Y, Minematsu K, Toyoda K, SAMURAI Study Investigators.
    Eur Neurol; 2011 Mar 15; 66(1):37-41. PubMed ID: 21709420
    [Abstract] [Full Text] [Related]

  • 20. The Cologne stroke experience: safety and outcome in 450 patients treated with intravenous thrombolysis.
    Sobesky J, Frackowiak M, Zaro Weber O, Hahn M, Möller-Hartmann W, Rudolf J, Neveling M, Grond M, Schmulling S, Jacobs A, Heiss WD.
    Cerebrovasc Dis; 2007 Mar 15; 24(1):56-65. PubMed ID: 17519545
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.